Latest Shareholder Impact News

Brightstar Resources has completed its acquisition of Aurumin Limited, converting Aurumin shares and options into Brightstar securities and prompting Aurumin’s imminent delisting from the ASX.

Vitasora Health has secured AU$3.56 million from a cornerstone investor, issuing over 118 million shares, while confirming compliance with key regulatory disclosure obligations.

Lynch Group Holdings confirms Federal Court approval of its acquisition scheme by Darwin Aus Bidco, with shares suspended and a cash payout scheduled. Shareholders await the next steps as the deal moves toward implementation.

InhaleRX Limited has announced a non-renounceable entitlement offer to raise approximately $247,668 by issuing nearly 10 million new shares at 2.5 cents each, accompanied by free attaching options. The offer opens on 5 December and closes on 17 December 2025.

Riedel Resources Limited has announced a 1 for 2 non-renounceable entitlement offer at $0.025 per share, aiming to raise approximately $1.78 million to fund exploration and working capital. The offer closes on 15 December 2025 and is open to eligible shareholders.

Forrestania Resources Limited has initiated an all-scrip off-market takeover offer for Kula Gold Limited, aiming to consolidate gold exploration assets across Western Australia. The offer, valued up to $58.7 million, comes with unanimous backing from Kula's board.

Wesfarmers Limited announces a fully franked special dividend of AUD 0.40 per share alongside a $1.10 capital return, both payable on December 4, 2025. Eligible shareholders can participate in the Dividend Investment Plan for the dividend component, marking a significant move in the company’s 2025 capital management strategy.

Elementos Limited has announced a $2.9 million non-renounceable entitlement offer alongside a $6 million initial placement to fund key project developments, including the Oropesa Tin Project and Cleveland Tin and Tungsten Project.

Infomedia Ltd’s acquisition by McQueen BidCo, backed by TPG Capital, has been legally approved, triggering trading suspension and scheduled shareholder payments.

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.

InFocus Group Holdings has extended its convertible note facility by $1 million, aiming to support growth in Thailand and new ventures in iGaming, pending shareholder approval.

Capricorn Metals Ltd has officially completed its acquisition of Warriedar Resources Limited through a court-approved scheme of arrangement, marking a significant consolidation in the gold mining sector.